Skip to main content

Table 3 The cross-sectional analysis for outcomes in lung transplant recipients with and without bronchiectasis

From: Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis

  All patients n = 124 Bronchiectasis n = 13 Non-bronchiectasis n = 111 p value
Median time of follow-up, months (IQR) 59 (21–99) 46 (15–89) 60 (21–100) 0.504
Death, n (%) 35 (28.2%) 5 (38.5%) 30 (27.0%) 0.515
Cause of death
 Infection 10 (26.6%) 3 (60.0%) 7 (23.3%) 0.642
 CLAD 9 (25.7%) 2 (40.0%) 7 (23.3%)  
 Primary graft dysfunction 6 (17.1%) 0 (0.0%) 6 (20.0%)  
 Cardiovascular complications 3 (8.6%) 0 (0.0%) 3 (10.0%)  
 Gastrointestinal complications 2 (5.7%) 0 (0.0%) 2 (6.7%)  
 Malignancy 2 (5.7%) 0 (0.0%) 2 (6.7%)  
 Technical complications 1 (2.9%) 0 (0.0%) 1 (3.3%)  
 Other 2 (5.7%) 0 (0.0%) 2 (6.7%)  
Median time to death, months (IQR) 15 (1–58) 25 (3–85) 14 (1–58) 0.775
CLAD, n (%) 35 (28.2%) 4 (30.8%) 31 (27.9%) 0.999
Median time to CLAD development, months (IQR) 60 (24–60) 24 (12–45) 72 (36–96) 0.036
Pseudomonas colonization, n (%) 29 (23.4%) 8 (61.5%) 21 (18.9%) 0.002
Median time to first isolation of Pseudomonas, months (IQR) 24 (6–78) 30 (4–93) 24 (9–66) 0.857
  1. LTX, lung transplant; IQR, interquartile range